hillo is a medtech start-up that leverages AI to transform diabetic patient's lives. Founded in 2016 and headquartered in France, the company operates in the AI, Health Care, and Medical Devices industries. It received a €1.30M Seed Round investment on 01 March 2020 from Angels Santé, Wille AG, and NCI Waterstart. This investment marks a significant milestone for hillo as it continues to innovate and make a positive impact in the medtech sector through the implementation of AI technologies to improve the lives of diabetic patients.
No recent news or press coverage available for hillo.